newsfilter
← Latest News
GlobeNewswire·

Lumos Pharma to Report First Quarter 2023 Financial Results and Host Conference Call on May 3, 2023

AUSTIN, Texas, April 19, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) through Phase 2